Business Insider

Occlutech granted important conditional FDA approval for PFO Study (OCCLUFLEX) in the U.S.

SCHAFFHAUSEN, Switzerland, Aug. 16, 2021 /PRNewswire/ -- Occlutech Holding AG ("Occlutech"), one of the world´s leading providers of minimally invasive structural heart disease devices, announces the ...
Morningstar

Recross Cardio Announces First Patient Enrolled in PROTEA-PFO US-Early Feasibility Study

Novel membrane-based PFO Sealing system designed to address limitations of current stroke prevention devices NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Recross Cardio Inc., a structural heart company ...
Houston Chronicle

Risk of recurrent strokes eliminated with FDA-approved procedure first studied in Houston

When Beaumont resident Janna Tarver noticed a nickel-size growth under her left arm, surgery was scheduled to remove it. But first, doctors asked her to see a cardiologist to ensure the surgery would ...
TCTMD

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

Both traditional and less conventional risk factors contribute strongly to the risk of cryptogenic ischemic stroke in adults younger than 50 years, but their relative importance varies by the presence ...